Medtronic Bone Graft Reimbursement Fate Fused With Stryker’s In CMS Rule
This article was originally published in The Gray Sheet
Executive Summary
CMS' proposed decision to deny a new-technology add-on to Medtronic's InFuse bone graft reaffirms that "substantial clinical improvement" ranks last in the hierarchy of evidence required for the payment
You may also be interested in...
St. Francis And Cardica Try For New Technology Add-On Payments In FY ’07
St. Francis Medical Technologies believes its X-Stop interspinous decompression device for lumbar spinal stenosis should qualify for a new technology add-on payment in FY '07 because it is a less invasive alternative to spinal fusion and laminectomy
St. Francis And Cardica Try For New Technology Add-On Payments In FY ’07
St. Francis Medical Technologies believes its X-Stop interspinous decompression device for lumbar spinal stenosis should qualify for a new technology add-on payment in FY '07 because it is a less invasive alternative to spinal fusion and laminectomy
BioMimetic Shifts Focus To Ortho Following Dental Combo Product Approval
BioMimetic Pharmaceuticals plans to initiate U.S. clinical studies for repairing bone fractures with device-biologic combination products in the first half of 2006